OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Treatment of Richter's syndrome
Philip A. Thompson, Tanya Siddiqi
Hematology (2022) Vol. 2022, Iss. 1, pp. 329-336
Open Access | Times Cited: 20
Philip A. Thompson, Tanya Siddiqi
Hematology (2022) Vol. 2022, Iss. 1, pp. 329-336
Open Access | Times Cited: 20
Showing 20 citing articles:
Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy for Richter Transformation: An International, Multicenter, Retrospective Study
Adam S. Kittai, David A. Bond, Ying Huang, et al.
Journal of Clinical Oncology (2024) Vol. 42, Iss. 17, pp. 2071-2079
Closed Access | Times Cited: 18
Adam S. Kittai, David A. Bond, Ying Huang, et al.
Journal of Clinical Oncology (2024) Vol. 42, Iss. 17, pp. 2071-2079
Closed Access | Times Cited: 18
Pirtobrutinib: A New Hope for patients with BTK-inhibitor refractory lymphoproliferative disorders
Philip A. Thompson, Constantine S. Tam
Blood (2023)
Open Access | Times Cited: 24
Philip A. Thompson, Constantine S. Tam
Blood (2023)
Open Access | Times Cited: 24
A multicenter study of venetoclax-based treatment for patients with Richter transformation of chronic lymphocytic leukemia
Paul J. Hampel, Mahesh Swaminathan, Kerry A. Rogers, et al.
Blood Advances (2024) Vol. 8, Iss. 10, pp. 2342-2350
Open Access | Times Cited: 7
Paul J. Hampel, Mahesh Swaminathan, Kerry A. Rogers, et al.
Blood Advances (2024) Vol. 8, Iss. 10, pp. 2342-2350
Open Access | Times Cited: 7
miRNA Biology in Chronic Lymphocytic Leukemia
Recep Bayraktar, Beatrice Fontana, George A. Călin, et al.
Seminars in Hematology (2024) Vol. 61, Iss. 3, pp. 181-193
Closed Access | Times Cited: 4
Recep Bayraktar, Beatrice Fontana, George A. Călin, et al.
Seminars in Hematology (2024) Vol. 61, Iss. 3, pp. 181-193
Closed Access | Times Cited: 4
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1)
Michele Bibas
Mediterranean Journal of Hematology and Infectious Diseases (2024) Vol. 16, Iss. 1, pp. e2024007-e2024007
Open Access | Times Cited: 3
Michele Bibas
Mediterranean Journal of Hematology and Infectious Diseases (2024) Vol. 16, Iss. 1, pp. e2024007-e2024007
Open Access | Times Cited: 3
Allogeneic hematopoietic stem-cell transplantation for patients with Richter transformation: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT
Romain Guièze, Diderik-Jan Eikema, Linda Köster, et al.
Bone Marrow Transplantation (2024) Vol. 59, Iss. 7, pp. 950-956
Closed Access | Times Cited: 3
Romain Guièze, Diderik-Jan Eikema, Linda Köster, et al.
Bone Marrow Transplantation (2024) Vol. 59, Iss. 7, pp. 950-956
Closed Access | Times Cited: 3
Venetoclax plus dose-adjusted R-EPOCH (VR-DA-EPOCH) or G-EPOCH bridging to subsequent cellular therapy for the patients with transformed lymphoma a single center clinical experience
Shuchao Qin, Rui Jiang, Luomengjia Dai, et al.
Annals of Hematology (2024) Vol. 103, Iss. 5, pp. 1635-1642
Open Access | Times Cited: 1
Shuchao Qin, Rui Jiang, Luomengjia Dai, et al.
Annals of Hematology (2024) Vol. 103, Iss. 5, pp. 1635-1642
Open Access | Times Cited: 1
Richter’s Syndrome (RS): Emerging Therapeutic Horizons
Jones Sr
Journal of Oncology Research and Therapy (2024) Vol. 9, Iss. 2
Open Access | Times Cited: 1
Jones Sr
Journal of Oncology Research and Therapy (2024) Vol. 9, Iss. 2
Open Access | Times Cited: 1
Decreased apoptotic priming and loss of BCL-2 dependence are functional hallmarks of Richter’s syndrome
Antonella Rigo, Tiziana Vaisitti, Carlo Laudanna, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 5
Open Access | Times Cited: 1
Antonella Rigo, Tiziana Vaisitti, Carlo Laudanna, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 5
Open Access | Times Cited: 1
Blinatumomab after R-CHOP bridging therapy for patients with Richter transformation: a phase 2 multicentre trial
Romain Guièze, Loïc Ysebaert, Damien Roos‐Weil, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Romain Guièze, Loïc Ysebaert, Damien Roos‐Weil, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Plasmablastic Lymphoma
Michele Bibas
Elsevier eBooks (2023), pp. 250-285
Closed Access | Times Cited: 2
Michele Bibas
Elsevier eBooks (2023), pp. 250-285
Closed Access | Times Cited: 2
Stem Cell Transplantation in Adult Lymphoma Patients
Mina Gendy, Marc Braunstein
Elsevier eBooks (2024), pp. 175-187
Closed Access
Mina Gendy, Marc Braunstein
Elsevier eBooks (2024), pp. 175-187
Closed Access
Are we closer to a standard of care for Richter’s syndrome? Novel treatments on the horizon
Nghia Pham, Catherine C. Coombs, Susan O’Brien
Expert Review of Hematology (2024) Vol. 17, Iss. 4-5, pp. 117-126
Open Access
Nghia Pham, Catherine C. Coombs, Susan O’Brien
Expert Review of Hematology (2024) Vol. 17, Iss. 4-5, pp. 117-126
Open Access
Lymphocytic Lymphoma Transforming into Hodgkin Lymphoma in Sub-Saharan Africa: Case Report and Literature Review
Sokhna Aïssatou Touré, Dibor Niang, Serigne Mourtalla Gueye, et al.
Hematology Reports (2024) Vol. 16, Iss. 3, pp. 523-528
Open Access
Sokhna Aïssatou Touré, Dibor Niang, Serigne Mourtalla Gueye, et al.
Hematology Reports (2024) Vol. 16, Iss. 3, pp. 523-528
Open Access
Molecular Subtypes and the Role of TP53 in Diffuse Large B-Cell Lymphoma and Richter Syndrome
Ivan Negara, Ciprian Tomuleasa, Sanda Buruiana, et al.
Cancers (2024) Vol. 16, Iss. 12, pp. 2170-2170
Open Access
Ivan Negara, Ciprian Tomuleasa, Sanda Buruiana, et al.
Cancers (2024) Vol. 16, Iss. 12, pp. 2170-2170
Open Access
Leukemia: Acute and Chronic
Sai Prasad Desikan, Sara Bresser, Alessandra Ferrajoli
Cambridge University Press eBooks (2024), pp. 304-330
Closed Access
Sai Prasad Desikan, Sara Bresser, Alessandra Ferrajoli
Cambridge University Press eBooks (2024), pp. 304-330
Closed Access
Implications of Genetic, Biological and Clinical Parameters in Patients With Richter Syndrome: A Monocentric Experience
Idanna Innocenti, Tommaso Quaranta, Annamaria Tomasso, et al.
Hematological Oncology (2024) Vol. 43, Iss. 1
Closed Access
Idanna Innocenti, Tommaso Quaranta, Annamaria Tomasso, et al.
Hematological Oncology (2024) Vol. 43, Iss. 1
Closed Access
Cytogenomic features of Richter transformation
Renata Woroniecka, Grzegorz Rymkiewicz, Zbigniew Bystydzieński, et al.
Molecular Cytogenetics (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Renata Woroniecka, Grzegorz Rymkiewicz, Zbigniew Bystydzieński, et al.
Molecular Cytogenetics (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Prospects of early therapeutic interventions for indolent adult T-cell leukemia/lymphoma based on the chronic lymphocytic leukemia progression model
Akihiro Ohmoto, Shigeo Fuji
Blood Reviews (2023) Vol. 60, pp. 101057-101057
Closed Access
Akihiro Ohmoto, Shigeo Fuji
Blood Reviews (2023) Vol. 60, pp. 101057-101057
Closed Access
Ibrutinib combined with gemcitabine-vinorelbine for primary refractory non-Hodgkin lymphoma
Mürüvvet Seda Aydın, Esra Cengiz, Ferda Can, et al.
Blood Research (2023) Vol. 58, Iss. 4, pp. 234-237
Open Access
Mürüvvet Seda Aydın, Esra Cengiz, Ferda Can, et al.
Blood Research (2023) Vol. 58, Iss. 4, pp. 234-237
Open Access
